The journal of nutrition, health & aging

, Volume 17, Issue 3, pp 235–239 | Cite as

Gait variability at fast-pace walking speed: A biomarker of mild cognitive impairment?

  • Olivier Beauchet
  • G. Allali
  • C. Launay
  • F. R. Herrmann
  • C. Annweiler



The interpretation of the increase in stride-to-stride variability of stride time (STV) regarding the evolution of cognitive deficits across the dementia spectrum is matter of debate.


The aim of this study was to compare STV at usual and fast-pace walking speeds of MCI patients with that of cognitively healthy individuals (CHI) and Alzheimer’s disease (AD) patients with mild dementia, while considering the effects of potential confounders.


STV while walking at usual and fast-pace walking speeds was recorded with the GAITRite® system from 116 older adults (mean age 75.6±6.5 years; 55.2% female) divided into 3 groups according to their cognitive status (44 CHI, 39 MCI patients and 33 AD patients with mild dementia).


The full adjusted multiple linear regression models showed that high STV was associated with slow gait speed at usual-pace walking speed (P=0.002) and with the MCI status at fast-pace walking speed (P=0.015).


High STV at fast-pace walking speed was a specific gait disturbance of MCI patients in the sample of studied participants, and thus could be used in the future as a specific biomarker of MCI patients.

Key words

Alzheimer’s disease mild cognitive impairment gait disorders stride-to-stride variability of stride time 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Beauchet O, Allali G, Berrut G, Hommet C, Dubost V, Assal F. Gait analysis in demented participants: Interests and perspectives. Neuropsychiatr Dis Treat. 2008;4:155–160.PubMedCrossRefGoogle Scholar
  2. 2.
    Verghese J, Wang C, Lipton RB, Holtzer R, Xue X. Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry 2007;78:929–935.PubMedCrossRefGoogle Scholar
  3. 3.
    Verghese J, Robbins M, Holtzer R, Zimmerman M, Wang C, Xue X. Gait dysfunction in mild cognitive impairment syndromes. J Am Geriatr Soc. 2008;56:1244–1251.PubMedCrossRefGoogle Scholar
  4. 4.
    Goldman WP, Baty JD, Buckles VD, Sahrmann S, Morris JC. Motor dysfunction in mildly demented AD individuals without extrapyramidal signs. Neurology 1999;53:956–962.PubMedCrossRefGoogle Scholar
  5. 5.
    Kluger A, Gianutsos JG, Golomb J, Ferris SH, George AE, Franssen E. Patterns of motor impairement in normal aging, mild cognitive decline, and early Alzheimer’s disease. J Gerontol B Psychol Sci Soc Sci. 1997;52:P28–39.PubMedCrossRefGoogle Scholar
  6. 6.
    Allali G, Assal F, Kressig RW, Dubost V, Herrmann FR, Beauchet O. Impact of impaired executive function on gait stability. Dement Geriatr Cogn Disord. 2008;26:364–369.PubMedCrossRefGoogle Scholar
  7. 7.
    Beauchet O, Allali G, Annweiler C, Bridenbaugh S, Assal F, Kressig RW. Gait variability among healthy adults: low and high stride-to-stride variability are both a reflection of gait stability. Gerontology 2009; 55: 702–706.PubMedCrossRefGoogle Scholar
  8. 8.
    Beauchet O, Annweiler C, Lecordroch Y, Allali G, Dubost V, Herrmann FR. Walking speed-related changes in stride time variability: effects of decreased speed. J Neuroeng Rehabil. 2009;6:32.PubMedCrossRefGoogle Scholar
  9. 9.
    Poujol L, Annweiler C, Allali G, Fantino B, Beauchet O. Effect of psychoactive medication on gait variability in community-dwelling older adults: a cross-sectional study. J Am Geriatr Soc. 2010;58:1207–1208.PubMedCrossRefGoogle Scholar
  10. 10.
    Beauchet O, Annweiler C, Lecordroch Y, Allali G, Dubost V, Herrmann FR, Kressig RW. Walking speed-related changes in stride time variability: effects of decreased speed. J Neuroeng Rehabil. 2009;6:32.PubMedCrossRefGoogle Scholar
  11. 11.
    Dubost V, Annweiler C, Aminian K, Najafi B, Herrmann FR, Beauchet O. Stride-tostride variability while enumerating animal names among healthy young adults: result of stride velocity or effect of attention-demanding task? Gait Posture. 2008;27:138–143PubMedCrossRefGoogle Scholar
  12. 12.
    Kressig RW, Beauchet O. Guidelines for clinical applications of spatio-temporal gait analysis in older adults. Aging Clin Exp Res. 2006;18:174–176PubMedGoogle Scholar
  13. 13.
    Annweiler C, Schott AM, Montero-Odasso M, Berrut G, Fantino B, Herrmann FR, Beauchet O. Cross-sectional association between serum vitamin D concentration and walking speed measured at usual and fast pace among older women: the EPIDOS study. J Bone Miner Res. 2010;25:1858–1866.PubMedCrossRefGoogle Scholar
  14. 14.
    Annweiler C, Fantino B, Schott AM, Krolak-Salmon P, Allali G, Beauchet O. Vitamin D insufficiency and mild cognitive impairment: cross-sectional association. Eur J Neurol. 2012;19:1023–1029.PubMedCrossRefGoogle Scholar
  15. 15.
    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198.PubMedCrossRefGoogle Scholar
  16. 16.
    Shah A, Herbert R, Lewis S, Mahendran R, Platt J, Bhattacharyya B. Screening for depression among acutely ill geriatric inpatients with a short Geriatric Depression Scale. Age Ageing 1997;26:217–221.PubMedCrossRefGoogle Scholar
  17. 17.
    Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology, 2000; 55:1621–1626.PubMedCrossRefGoogle Scholar
  18. 18.
    Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry 1984; 141:1356–1364.PubMedGoogle Scholar
  19. 19.
    Brown EC, Casey A, Fisch RI, Neuringer C. Trail making test as a screening device for the detection of brain damage. J Consult Psychol. 1958;22:469–474.PubMedCrossRefGoogle Scholar
  20. 20.
    Grober E, Buschke H, Crystal H, Bang S, Dresner R. Screening for dementia by memory testing. Neurology. 1988;38:900–903.PubMedCrossRefGoogle Scholar
  21. 21.
    Van der Linden M, Coyette F, Poitrenaud F, Kalafat M, Calicis F, Adam, F. L’épreuve de rappel libre/rappel indicé à 16 items (RL/RI-16). In L’évaluation des troubles de la mémoire, (ed. Solal ), 2004, Marseille.Google Scholar
  22. 22.
    Pérès K, Chrysostome V, Fabrigoule C, Orgogozo JM, Dartigues JF, Barberger-Gateau P. Restriction in complex activities of daily living in MCI: impact on outcome. Neurology 2006;67:461–466.PubMedCrossRefGoogle Scholar
  23. 23.
    Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO. Mild cognitive impairment—beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240–246.PubMedCrossRefGoogle Scholar
  24. 24.
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.PubMedCrossRefGoogle Scholar
  25. 25.
    Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55:967–972.PubMedCrossRefGoogle Scholar
  26. 26.
    Rosano C, Brach J, Studenski S, Longstreth WT, Jr., Newman AB. Gait variability is associated with subclinical brain vascular abnormalities in high-functioning older adults. Neuroepidemiology 2007;29:193–200.PubMedCrossRefGoogle Scholar
  27. 27.
    Zimmerman ME, Lipton RB, Pan JW, Hetherington HP, Verghese J. MRI- and MRS-derived hippocampal correlates of quantitative locomotor function in older adults. Brain Res. 2009;1291:73–81.PubMedCrossRefGoogle Scholar
  28. 28.
    Scherder E, Eggermont L, Swaab D, van Heuvelen M, Kamsma Y, de Greef M. Gait in ageing and associated dementias; its relationship with cognition. Neurosci Biobehav Rev 2007;31:485–497.PubMedCrossRefGoogle Scholar
  29. 29.
    Dickerson BC, Sperling RA. Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer’s disease: insights from functional MRI studies. Neuropsychologia 2008;46:1624–1635.PubMedCrossRefGoogle Scholar
  30. 30.
    Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P. Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol. 2011;9:1118–1127.CrossRefGoogle Scholar
  31. 31.
    Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDSADRDA criteria. Lancet Neurol. 2007;6:734–746.PubMedCrossRefGoogle Scholar

Copyright information

© Serdi and Springer-Verlag France 2012

Authors and Affiliations

  • Olivier Beauchet
    • 1
    • 2
    • 5
  • G. Allali
    • 3
  • C. Launay
    • 1
  • F. R. Herrmann
    • 4
  • C. Annweiler
    • 1
  1. 1.Department of Neuroscience, Division of Geriatric MedicineAngers University HospitalAngersFrance
  2. 2.UPRES EA 2646University of Angers, UNAMAngersFrance
  3. 3.Department of NeurologyGeneva University Hospital and University of GenevaGenevaSwitzerland
  4. 4.Department of Rehabilitation and GeriatricsGeneva University Hospitals and University of GenevaGenevaSwitzerland
  5. 5.Department of Neuroscience, Division of Geriatric MedicineAngers University HospitalAngers Cedex 9France

Personalised recommendations